Vivesto AB (STO:VIVE)
Sweden · Delayed Price · Currency is SEK 0.0980
+0.0130 (15.29%)
At close: Feb 10, 2026
Vivesto AB Market Cap
Vivesto AB has a market cap or net worth of 55.77 million as of February 10, 2026. Its market cap has decreased by -54.83% in one year.
Market Cap
55.77M
Enterprise Value
54.31M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
Market Cap Chart
Since August 11, 2006, Vivesto AB's market cap has decreased from 1.15B to 55.77M, a decrease of -95.15%. That is a compound annual growth rate of -14.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 55.77M | -23.22% |
| Dec 30, 2025 | 72.64M | -53.45% |
| Dec 30, 2024 | 156.03M | -28.83% |
| Dec 29, 2023 | 219.25M | -6.11% |
| Dec 30, 2022 | 233.51M | -80.14% |
| Dec 30, 2021 | 1.18B | -36.33% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EQL Pharma AB | 1.91B |
| Orexo AB | 1.03B |
| Cinclus Pharma Holding AB | 777.18M |
| Dicot Pharma AB | 650.02M |
| Nanexa AB | 601.56M |
| Enzymatica AB | 449.06M |
| Moberg Pharma AB | 445.57M |
| Klaria Pharma Holding AB (publ.) | 227.77M |